Table 5.
Effect of quinonoids in inhibiting angiogenesis, tumor migration, and invasion.
| Quinonoids | Cell lines or animal models | Doses | Targets | Pharmacodynamic effects | Ref. |
|---|---|---|---|---|---|
| Emodin | A549 cells | 0.1~10 μM | P2Y receptors, NF-κB | Inhibit cell proliferation, migration, and EMT | [41] |
| A549 cells | 50~100 μM | CXCR4, CXCL12, HER2, NF-κB | Inhibit cell migration and invasion | [42] | |
|
| |||||
| Plumbagin | A549 cells A549 xenograft nude mice |
1~8 μM 5 mg/kg |
FAK, Akt, ROCK1, LIMK1/2, cofilin | Reduce OPN-induced invasion, suppress lung metastasis | [43] |
| L9981 and NL9980 cells | 3~12 μM | IL-6, STAT3 | Inhibit cell proliferation and invasion | [44] | |
|
| |||||
| Thymoquinone | A549 cells | 5~160 μM | ERK1/2, PCNA, cyclin D1, MMP2, and MMP9 | Inhibit cell proliferation, migration, and invasion | [45] |
|
| |||||
| Tanshinone IIA | A549 cells | 2.5~80 μM | VEGF, VEGFR2 | Inhibit proliferation by blocking cell cycle and inducing apoptosis and inhibit angiogenesis | [46] |
|
| |||||
| Acetylshikonin | A549 cells LLC-bearing mice |
5~20 μM 2 mg/kg |
uPA | Inhibit angiogenesis and tumorigenesis | [47] |
|
| |||||
| Denbinobin | A549 cells A549 xenograft mice |
0.1~10 μM 25 mg/kg |
IGF-1R, ERK, Akt, mTOR, p70S6K, 4EBP, and cyclin D1 | Inhibit IGF-1-induced angiogenesis in vitro and in vivo | [48] |
|
| |||||
| Salvicine | A549 cells | 0.625~200 μM | bFGF | Inhibit angiogenesis | [49] |